NinePointTwo Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,741
Closed -$255K 306
2023
Q2
$255K Sell
3,741
-1,997
-35% -$129K 0.1% 123
2023
Q1
$278K Buy
+5,738
New +$303K 0.1% 57
2022
Q4
Sell
-15,290
Closed -$927K 242
2022
Q3
$927K Buy
15,290
+871
+6% +$27.5K 0.37% 19
2022
Q2
$391K Buy
14,419
+2,945
+26% +$86.2K 0.14% 74
2022
Q1
$419K Buy
11,474
+5,302
+86% +$191K 0.11% 56
2021
Q4
$304K Buy
+6,172
New +$342K 0.1% 59

Other funds holding PRTA

NinePointTwo Capital's PRTA Position: Q3 2023 in Review

NinePointTwo Capital sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 3,741 shares — an estimated $255K sold.

NinePointTwo Capital first reported a position in PRTA in Q4 2021 and held it in 6 quarters. The position peaked at $927K in Q3 2022. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

  • NinePointTwo Capital reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
  • NinePointTwo Capital sold 3,741 Prothena Corp shares in Q3 2023, an estimated $255K.
  • NinePointTwo Capital first reported a position in Prothena Corp in Q4 2021 and held it in 6 quarters.
  • NinePointTwo Capital's Prothena Corp position peaked at $927K in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on NinePointTwo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.